Rollins

US · ROL #1155 by market cap Listed 1970

30.87 +0.52 +1.71%

Live - 5344 symbols - heartbeat 20s ago · 2026-10-08 07:24

Pre-market 31.18 +1.00%

After-hours 31.28 +1.33%

Overnight 30.91 +0.13%

Market cap: 14.85B
P/E (TTM): 28.06
P/B: 10.39
EPS: 1.09
Div yield: 2.31%
52W pos: 4%

Reader sentiment Are you bullish or bearish on ROL?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Good

Altman Z-Score is 7.22, above the 3.0 "safe zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +10.99% YoY

Margins

Gross margin: 52.75%
Operating margin: 19.30%
Net margin: 14.00%

Key ratios & quality

Enterprise value: 15.50B
PEG ratio: 2.22
Altman Z-Score: 7.22

PEG uses trailing P/E against the 3-year net income growth rate (12.63%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	1.82B	2.02B	2.16B	2.42B	2.70B	3.07B	3.39B	3.76B
Gross profit	927.13M	1.02B	1.11B	1.26B	1.39B	1.60B	1.79B	1.98B
Selling & admin expenses	550.70M	623.38M	657.21M	727.49M	802.71M	915.23M	1.02B	1.13B
Research & development	--	--	--	--	--	--	--	--
Operating profit	309.64M	317.39M	376.09M	447.64M	493.39M	588.42M	657.22M	726.07M
Pretax profit	310.73M	261.16M	362.72M	482.49M	498.92M	586.26M	630.23M	700.93M
Tax	79.07M	57.81M	95.96M	125.92M	130.32M	151.30M	163.85M	174.22M
Net profit	231.66M	203.35M	266.76M	356.57M	368.60M	434.96M	466.38M	526.71M
Basic EPS	0	0	1	1	1	1	1	1
Diluted EPS	0.47	0.41	0.54	0.72	0.75	0.89	0.96	1.09

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	822.50M	999.53M	1.03B	912.91M	906.42M	1.08B
Gross profit	422.37M	537.67M	558.66M	465.35M	460.90M	569.95M
Selling & admin expenses	250.51M	307.60M	301.40M	273.72M	282.92M	334.98M
Research & development	--	--	--	--	--	--
Operating profit	142.65M	198.33M	225.02M	160.07M	145.49M	201.36M
Pretax profit	137.54M	191.25M	217.43M	154.71M	137.10M	189.75M
Tax	32.30M	49.76M	53.90M	38.27M	29.26M	45.84M
Net profit	105.25M	141.49M	163.53M	116.44M	107.84M	143.91M
Basic EPS	0	0	0	0	0	0
Diluted EPS	0.22	0.29	0.34	0.24	0.22	0.30

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	286.02M	309.79M	314.78M	352.38M	348.62M	406.64M	442.62M	472.68M
Cash & ST investments	115.49M	94.28M	98.48M	105.30M	95.35M	103.83M	89.63M	100.00M
Inventory	15.79M	19.48M	30.84M	28.93M	29.75M	33.38M	39.53M	42.98M
Total assets	1.09B	1.74B	1.85B	2.02B	2.12B	2.60B	2.82B	3.14B
Total current liabilities	299.03M	410.04M	472.51M	491.16M	493.78M	576.69M	645.16M	785.53M
Short-term debt	--	78.62M	90.44M	93.99M	99.54M	92.20M	121.32M	261.09M
Long-term debt	--	279.00M	185.81M	136.25M	39.90M	490.78M	395.31M	486.15M
Total liabilities	382,216,000.00	928,626,000.00	904,540,000.00	910,323,000.00	854,831,000.00	1,439,893,000.00	1,489,102,000.00	1,766,202,000.00
Total equity	711.91M	815.75M	941.36M	1.11B	1.27B	1.16B	1.33B	1.37B
Retained earnings	370.29M	256.30M	358.89M	530.09M	687.07M	566.40M	734.65M	738.92M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	555.97M	537.91M	550.71M	472.68M	513.68M	590.40M
Cash & ST investments	201.18M	123.04M	127.36M	100.00M	116.54M	109.09M
Inventory	41.25M	43.24M	43.48M	42.98M	44.13M	42.81M
Total assets	2.95B	3.18B	3.22B	3.14B	3.16B	3.35B
Total current liabilities	636.82M	788.08M	712.84M	785.53M	794.66M	938.10M
Short-term debt	127.46M	190.81M	134.24M	261.09M	300.64M	354.60M
Long-term debt	485.45M	485.28M	485.66M	486.15M	486.63M	487.11M
Total liabilities	1,592,806,000.00	1,736,169,000.00	1,687,612,000.00	1,766,202,000.00	1,778,546,000.00	1,925,335,000.00
Total equity	1.36B	1.44B	1.53B	1.37B	1.38B	1.43B
Retained earnings	759.99M	822.01M	905.46M	738.92M	758.78M	794.96M

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	299.40M	319.57M	435.79M	401.81M	465.93M	528.37M	607.65M	678.11M
Depreciation & amortization	64.68M	81.11M	79.33M	86.56M	91.33M	99.75M	113.22M	124.74M
Free cash flow	272.22M	292.43M	412.56M	374.61M	435.30M	495.90M	580.08M	650.02M
Dividends paid	-152.74M	-153.84M	-160.49M	-208.66M	-211.62M	-264.35M	-297.99M	-327.90M
Stock buybacks / issuance	-9.54M	-10.01M	-8.28M	-10.69M	-7.07M	-315.01M	-11.61M	-216.86M
Ending cash balance	115.49M	94.28M	98.48M	105.30M	95.35M	103.83M	89.63M	100.00M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	146.89M	175.12M	191.35M	164.74M	118.37M	172.51M
Depreciation & amortization	29.21M	31.74M	32.23M	31.57M	32.50M	33.61M
Free cash flow	140.11M	168.05M	182.85M	159.02M	111.23M	166.08M
Dividends paid	-79.91M	-79.46M	-80.08M	-88.45M	-87.85M	-88.09M
Stock buybacks / issuance	-14.67M	-251.00K	-3.65M	-198.28M	-22.35M	-20.48M
Ending cash balance	201.18M	123.04M	127.36M	100.00M	116.54M	109.09M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	33.92	26.62	29.69	34.66	31.38	35.91	37.52	38.94
ROA %	21.78	14.33	14.53	18.33	17.97	18.44	17.23	17.67
ROIC %	33.92	16.18	19.56	24.71	24.00	25.12	23.66	24.07
5-year avg ROE %	31.05	30.27	30.17	30.99	31.33	31.73	33.91	35.62
EBIT margin %	17.00	15.75	16.72	19.62	18.60	19.70	19.41	19.40
FCF / sales %	14.22	13.99	19.09	15.45	16.15	16.14	17.12	17.28
Current ratio	0.96	0.76	0.67	0.72	0.71	0.71	0.69	0.60
Quick ratio	0.80	0.58	0.53	0.55	0.58	0.55	0.51	0.44
Debt / assets	0.00	28.28	22.60	19.92	15.85	31.45	28.82	33.05
LT debt / equity	--	50.83	34.71	27.79	18.69	62.67	51.95	56.53
Interest coverage	--	--	--	573.09	190.13	31.77	23.77	25.54
Revenue CAGR (3Y) %	7.04	8.60	8.89	10.00	10.18	12.45	11.81	11.74
Net income CAGR (3Y) %	15.04	6.71	14.20	15.46	21.93	17.70	9.36	12.63
FCF CAGR (3Y) %	20.17	14.77	25.11	11.23	14.18	6.33	15.69	14.30

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	37.83	36.52	36.21	38.94	38.67	37.01
ROA %	17.02	16.46	17.10	17.67	17.33	16.27
ROIC %	23.14	22.47	23.27	24.07	23.46	22.49
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	19.32	19.18	19.50	19.40	19.04	18.67
FCF / sales %	17.32	17.69	18.34	17.28	16.15	15.78
Current ratio	0.87	0.68	0.77	0.60	0.65	0.63
Quick ratio	0.68	0.50	0.58	0.44	0.47	0.42
Debt / assets	30.90	30.41	28.33	33.05	33.77	33.24
LT debt / equity	57.80	53.77	50.77	56.53	55.48	53.21
Interest coverage	25.98	27.01	27.45	25.54	23.16	21.79
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Lead segment, long tail

Residential revenues is the largest reported line at 45.05% of revenue, across 5 reported segments.
Commercial revenues follows at 32.26%, so the top line still matters most but isn’t the whole story.

Revenue breakdown most recent period

Business

Residential revenues45.05%

Commercial revenues32.26%

Termite and ancillary revenues21.71%

Other revenues0.57%

Franchise revenues0.42%

Quote time 2026-10-08 07:24:01 · For reference only, not investment advice and not tailored to your situation.